Pages that link to "Q36696611"

The following pages link to ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. (Q36696611):

Displaying 6 items.

• Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts (Q33863907) ‎ (← links)
• Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors (Q34741259) ‎ (← links)
• Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study (Q34992944) ‎ (← links)
• Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel. (Q36611295) ‎ (← links)
• Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models. (Q41552582) ‎ (← links)
• In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes. (Q53561434) ‎ (← links)